3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
17
Recruiting
7
Withdrawn
1
Unknown
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Colorectal Neoplasms
13
Pancreatic Neoplasms
7
Cholangiocarcinoma
5
Cirrhosis, Familial, with Pulmonary Hypertension
3
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Stomach Neoplasms
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Gastroesophageal Junction Cancer
1
Esophageal Squamous Cell Carcinoma
1
Efficacy and Safety
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
CRC
1
Biliary Cancer Metastatic
1
Appendiceal Neoplasms
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Oxaliplatin
4
Capecitabine
3
Radiotherapy
2
Docetaxel
2
Androgen Antagonists
2
tislelizumab
1
pembrolizumab
1
luprolide acetate gel depot
1
lenvatinib
1
enzalutamide
1
cemiplimab
1
Surgical Procedures, Operative
1
Radiotherapy, Image-Guided
1
Poly(ADP-ribose) Polymerase Inhibitors
1
PF06821497
1
Negative-Pressure Wound Therapy
1
Leuprolide
1
Leucovorin
1
Injections
1
Fluorouracil
1
Drug Therapy
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma
×
Leucovorin
×
Clear all
NCT07118800
2025-08-12
NACRE-2
UNICANCER
Phase 3
Not yet recruiting
160 enrolled